Thyroid tablets recalled nationwide due to potential over-potency risk

A pharmaceutical company called Vitruvias Therapeutics is recalling thyroid medication tablets because testing showed they may be stronger than their label indicates, which could cause health problems for people taking them.

15 across the spectrum. Choose a side on the bar to jump to it.

National story. 31 articles from 15 sources. Updated Aug 27, 2026.

How each side is putting it

Left

4 sources
Ran by 4 outlets across the spectrum· Cleveland Plain Dealer, NJ.com / Star-Ledger
Cleveland Plain DealerLean Left· Aug 25, 2026

‘Superpotent’ thyroid medication recalled as batch could cause serious health problems

NJ.com / Star-LedgerLean Left· Aug 25, 2026

‘Superpotent’ thyroid medication recalled as batch could cause serious health problems

QuartzLean Left· Aug 25, 2026

Vitruvias Therapeutics is recalling thyroid tablets that may be too strong

Money Talks NewsLean Left· Aug 25, 2026

Thyroid Medicine Recalled: See Affected Product

Center

9 sources
MedicalXpressCenter· Aug 27, 2026

Thyroid tablets recalled nationwide due to potential over-potency risk

Ran by 16 outlets· Our Quad Cities, WFLA, +14 more
Our Quad CitiesCenter· Aug 26, 2026

Thyroid medication recalled nationwide due to possible 'superpotency' issue

WFLACenter· Aug 25, 2026

Thyroid medication recalled nationwide due to possible 'superpotency' issue

WGN ChicagoCenter· Aug 25, 2026

Thyroid medication recalled nationwide due to possible 'superpotency' issue

KSN WichitaCenter· Aug 25, 2026

Thyroid medication recalled nationwide due to possible 'superpotency' issue

KRQE AlbuquerqueCenter· Aug 25, 2026

Thyroid medication recalled nationwide due to possible 'superpotency' issue

FOX8 WGHPCenter· Aug 25, 2026

Thyroid medication recalled nationwide due to possible 'superpotency' issue

WCBD News 2Center· Aug 25, 2026

Thyroid medication recalled nationwide due to possible 'superpotency' issue

KHON 2 HonoluluCenter· Aug 25, 2026

Thyroid medication recalled nationwide due to possible 'superpotency' issue

MyarklamissCenter· Aug 25, 2026

Thyroid medication recalled nationwide due to possible 'superpotency' issue

Mycham Plain ValleyCenter· Aug 25, 2026

Thyroid medication recalled nationwide due to possible 'superpotency' issue

KTSM 9 NewsCenter· Aug 25, 2026

Thyroid medication recalled nationwide due to possible 'superpotency' issue

FOX 21 Colorado SpringsCenter· Aug 25, 2026

Thyroid medication recalled nationwide due to possible 'superpotency' issue

WWLP SpringfieldCenter· Aug 25, 2026

Thyroid medication recalled nationwide due to possible 'superpotency' issue

MytwintiersCenter· Aug 25, 2026

Thyroid medication recalled nationwide due to possible 'superpotency' issue

WHNTCenter· Aug 25, 2026

Thyroid medication recalled nationwide due to possible 'superpotency' issue

Phl17Center· Aug 25, 2026

Thyroid medication recalled nationwide due to possible 'superpotency' issue

The OregonianCenter· Aug 25, 2026· ran in 4 outlets

‘Superpotent’ thyroid medication recalled as batch could cause serious health problems

Ran by 2 outlets· WKBN Youngstown, FOX 8 Cleveland
WKBN YoungstownCenter· Aug 25, 2026

Thyroid tablets could be 'superpotent,' warns FDA in urgent recall alert

FOX 8 ClevelandCenter· Aug 25, 2026

Thyroid tablets could be 'superpotent,' warns FDA in urgent recall alert

Ran by 2 outlets· The Hill, News Nation Now
The HillCenter· Aug 25, 2026

Thyroid tablets recalled nationwide over potential 'superpotency': FDA

News Nation NowCenter· Aug 25, 2026

Thyroid tablets recalled nationwide over potential 'superpotency': FDA

Right

2 sources
AL.comLean Right· Aug 25, 2026· ran in 4 outlets

‘Superpotent’ thyroid medication recalled as batch could cause serious health problems

FOX BusinessLean Right· Aug 25, 2026

Thyroid medication recalled nationwide after tablets found to be 'superpotent': FDA

The bigger story

This story is one of several related ones. Here's where it sits.

You are hereAug 24, 2026

Thyroid tablets recalled nationwide due to potential over-potency risk

15 sources